Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN115504870B enables high-purity 4-methoxy-2-naphthol production with improved yield and supply chain reliability for global pharmaceutical manufacturers.
Novel rhodium-catalyzed route for indaziflam intermediate offers high ee value and industrial scalability for agrochemical supply chains.
Novel safe route avoids toxic gas. High purity intermediate for pharma. Cost-effective scalable production for global supply chains.
Patent CN1121706A reveals a non-halide route for substituted aromatic amines, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel asymmetric hydrogenation ligand CN120484023A ensures high ee and scalable production for pharmaceutical intermediates manufacturing supply chains.
Patent CN110526944A reveals high-efficiency Ru catalyst for asymmetric transfer hydrogenation, offering cost reduction and supply reliability.
Novel patent CN116283604B details high-purity spermidine synthesis offering scalable production and supply chain stability for global pharmaceutical manufacturers.
Patent CN110330400A reveals Rh-catalyzed hydrogenation for high-purity intermediates. Offers cost reduction and supply reliability for pharma manufacturing partners seeking scalable solutions.
Patent CN114644614B details a novel 3-step synthesis for L-nicotine achieving >99.9% optical purity. Discover cost-effective, scalable manufacturing solutions for pharmaceutical intermediates.
Patent CN114644614B reveals a novel 3-step route to L-nicotine with >99.9% ee. Discover cost-effective manufacturing and supply chain advantages for pharma intermediates.
Patent CN103265616A details a green, cost-effective synthesis of N(2)-L-alanyl-L-glutamine using aqueous acylation and stereoselective hydrogenation, offering significant supply chain advantages.
Patent CN114437085A details a safe, high-yield route for Rucaparib intermediates, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain stability.
Patent CN107200708B reveals a novel 3-step synthesis for Vismodegib using 2-chloro-5-nitroacetophenone, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN102108069A details a mild, scalable route for 6-benzothiazole sulfonyl chloride. Discover cost-effective manufacturing for HIV inhibitor intermediates.
Novel scalable route for (3R,6S)-1-benzyl-6-methylpiperidine-3-amine avoiding chiral chromatography, offering cost-effective API manufacturing solutions.
Patent CN112159360B details a green ruthenium-catalyzed route for triazine derivatives, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Novel ferrocene-based PNO ligand patent CN113004341B enables high-selectivity asymmetric hydrogenation for cost-effective pharmaceutical intermediate manufacturing and supply chain stability.
Patent CN1566084A reveals novel water-soluble diamines enabling green asymmetric hydrogenation. Discover cost-effective API intermediate manufacturing solutions.
Patent CN103408459B details a high-yield route for 4-cyanophenylalanine. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN103304472A details a high-yield synthesis of 1-BOC-3-piperidone via Oppenauer oxidation, offering significant cost reduction in API manufacturing and scalable production capabilities.